This text investigates the clinical relationship between exogenous hormone exposure and the increased risk of venous thromboembolism in female patients. Ian A. Greer, a prominent figure in obstetric hematology, synthesizes clinical data and epidemiological studies to evaluate how pregnancy, oral contraceptives, and hormone replacement therapy influence coagulation pathways. The work provides a structured framework for risk assessment and management strategies in clinical practice.

Medical professionals and researchers frequently cite this work as a foundational reference for understanding the intersection of reproductive endocrinology and hematology. Experts highlight the clinical utility of the text in guiding evidence-based decision-making for high-risk patient populations.